Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including activist Glenview Capital pressured ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...

CVS Health said Friday CEO Karen Lynch has stepped down after the pharmacy chain once again warned its earnings will fall short of Wall Street's forecasts. Lynch will be replaced by CVS Caremark ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. … CVS Health is naming longtime executive David Joyner as its new chief, succeeding Karen Lynch at the helm of ...

CVS Health CEO Karen Lynch has stepped down with company shares sinking 19% this year and the healthcare giant struggling on several fronts. Company shares tumbled again Friday after CVS Health ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...